Medical Management of Glaucoma in the 21st Century from a Canadian Perspective

Glaucoma is a medical term describing a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and resulting in changes in the optic nerve head. Glaucoma is a leading cause of irreversible vision loss worldwide. With the aging po...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Harasymowycz, Catherine Birt, Patrick Gooi, Lisa Heckler, Cindy Hutnik, Delan Jinapriya, Lesya Shuba, David Yan, Radmila Day
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2016/6509809
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560335607824384
author Paul Harasymowycz
Catherine Birt
Patrick Gooi
Lisa Heckler
Cindy Hutnik
Delan Jinapriya
Lesya Shuba
David Yan
Radmila Day
author_facet Paul Harasymowycz
Catherine Birt
Patrick Gooi
Lisa Heckler
Cindy Hutnik
Delan Jinapriya
Lesya Shuba
David Yan
Radmila Day
author_sort Paul Harasymowycz
collection DOAJ
description Glaucoma is a medical term describing a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and resulting in changes in the optic nerve head. Glaucoma is a leading cause of irreversible vision loss worldwide. With the aging population it is expected that the prevalence of glaucoma will continue to increase. Despite recent advances in imaging and visual field testing techniques that allow establishment of earlier diagnosis and treatment initiation, significant numbers of glaucoma patients are undiagnosed and present late in the course of their disease. This can lead to irreversible vision loss, reduced quality of life, and a higher socioeconomic burden. Selection of therapeutic approaches for glaucoma should be based on careful ocular examination, patient medical history, presence of comorbidities, and awareness of concomitant systemic therapies. Therapy should also be individualized to patients’ needs and preferences. Recent developments in this therapeutic field require revisiting treatment algorithms and integration of traditional and novel approaches in order to ensure optimal visual outcomes. This article provides an overview of recent developments and practice trends in the medical management of glaucoma in Canada. A discussion of the surgical management is beyond the scope of this paper.
format Article
id doaj-art-ab468653c3ee4cd78bf0245438a946b9
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-ab468653c3ee4cd78bf0245438a946b92025-02-03T01:27:52ZengWileyJournal of Ophthalmology2090-004X2090-00582016-01-01201610.1155/2016/65098096509809Medical Management of Glaucoma in the 21st Century from a Canadian PerspectivePaul Harasymowycz0Catherine Birt1Patrick Gooi2Lisa Heckler3Cindy Hutnik4Delan Jinapriya5Lesya Shuba6David Yan7Radmila Day8Université de Montréal, Montreal, QC, CanadaUniversity of Toronto, Toronto, ON, CanadaUniversity of Calgary, Calgary, AB, CanadaUniversité de Montréal, Montreal, QC, CanadaWestern University, London, ON, CanadaQueen’s University, Kingston, ON, CanadaDalhousie University, Halifax, NS, CanadaUniversity of Toronto, Toronto, ON, CanadaSNELL Medical Communication Inc., Montreal, QC, CanadaGlaucoma is a medical term describing a group of progressive optic neuropathies characterized by degeneration of retinal ganglion cells and retinal nerve fibre layer and resulting in changes in the optic nerve head. Glaucoma is a leading cause of irreversible vision loss worldwide. With the aging population it is expected that the prevalence of glaucoma will continue to increase. Despite recent advances in imaging and visual field testing techniques that allow establishment of earlier diagnosis and treatment initiation, significant numbers of glaucoma patients are undiagnosed and present late in the course of their disease. This can lead to irreversible vision loss, reduced quality of life, and a higher socioeconomic burden. Selection of therapeutic approaches for glaucoma should be based on careful ocular examination, patient medical history, presence of comorbidities, and awareness of concomitant systemic therapies. Therapy should also be individualized to patients’ needs and preferences. Recent developments in this therapeutic field require revisiting treatment algorithms and integration of traditional and novel approaches in order to ensure optimal visual outcomes. This article provides an overview of recent developments and practice trends in the medical management of glaucoma in Canada. A discussion of the surgical management is beyond the scope of this paper.http://dx.doi.org/10.1155/2016/6509809
spellingShingle Paul Harasymowycz
Catherine Birt
Patrick Gooi
Lisa Heckler
Cindy Hutnik
Delan Jinapriya
Lesya Shuba
David Yan
Radmila Day
Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
Journal of Ophthalmology
title Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
title_full Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
title_fullStr Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
title_full_unstemmed Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
title_short Medical Management of Glaucoma in the 21st Century from a Canadian Perspective
title_sort medical management of glaucoma in the 21st century from a canadian perspective
url http://dx.doi.org/10.1155/2016/6509809
work_keys_str_mv AT paulharasymowycz medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT catherinebirt medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT patrickgooi medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT lisaheckler medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT cindyhutnik medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT delanjinapriya medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT lesyashuba medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT davidyan medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective
AT radmiladay medicalmanagementofglaucomainthe21stcenturyfromacanadianperspective